Related Experiment Video

Updated: Apr 17, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells

Julio Vera1, Yvonne Raatz2, Olaf Wolkenhauer3

  • 1Laboratory of Systems Tumor Immunology, Department of Dermatology, University Hospital Erlangen and Friedrich-Alexander-University Erlangen-Nürnberg, Ulmenweg 18, 91054 Erlangen, Germany.

Cellular Signalling
|February 17, 2015
PubMed

Insights

Melanoma cells utilize ATR-Chk1-Wee1 and ATM-Chk2-p53-p21 pathways for cell cycle control. Chk1 inhibition alone or with doxorubicin can enhance apoptosis, suggesting a potential therapeutic strategy for melanoma.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Melanoma cells employ intricate cell cycle control pathways, including ATR-Chk1-Wee1 and ATM-Chk2-p53-p21, in response to cellular stress.
  • Understanding these pathways is crucial for developing effective therapeutic strategies against melanoma, a significant form of skin cancer.
  • Doxorubicin, a genotoxic agent, is known to induce cell cycle arrest and apoptosis in cancer cells.

Purpose of the Study:

  • To analyze the roles of ATR-Chk1-Wee1 and ATM-Chk2-p53-p21 pathways in stress-induced cell cycle regulation within melanoma cells.
  • To investigate the impact of inhibiting key kinases (Chk1, Wee1) and the p53/p21 axis on cell cycle arrest and apoptosis.
  • To evaluate the potential of combined therapeutic approaches involving doxorubicin and kinase inhibitors for overcoming apoptosis resistance in melanoma.

Main Methods:

  • Treatment of wild-type p53 and p53-mutant melanoma cells with doxorubicin, a genotoxic agent.
  • Utilized inhibitors targeting Chk1, Wee1, and ATM (Chk2 upstream kinase).
  • Assessed cell cycle arrest (G0-G1 and G2-M phases), apoptosis induction, and expression levels of p53 and p21.

Main Results:

  • Doxorubicin treatment induced G2-M arrest, inhibitory phosphorylation of Cdc2 (CDK1), and elevated p53/p21 expression in p53 wild-type melanoma cells.
  • Inhibition of Chk1 or Wee1 under doxorubicin treatment modulated G2-M arrest and enhanced apoptosis; Chk1 inhibition alone also increased apoptosis.
  • Chk1 inhibition disrupted G0-G1 arrest, while p53, p21, and Chk1 were identified as key mediators of G0-G1 arrest, particularly in response to combined treatments.

Conclusions:

  • Chk1 and Wee1 are critical mediators of G2-M arrest in melanoma cells.
  • p53, p21, and Chk1 play significant roles in regulating G0-G1 arrest.
  • Combined treatment with doxorubicin and Chk1 inhibitors shows promise for overcoming apoptosis resistance in p53-proficient melanoma, with Chk1 inhibition alone potentially being more effective.
Keywords:
Cell cycleCell signallingChk1Tumour biologyWee1

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.8K
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

18.9K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K